Pharmaceutical Executive October 13, 2025
The current administration’s efforts are just the latest attempt from the government to improve drug prices in the US.
Pharmaceutical Executive: How will pharma companies react to the administration’s efforts?
Dr. William Soliman: We’ve seen Pfizer doing a deal with Trump, and I think other companies will follow. If they can come to a compromise for even just some branded drugs, that’s a happy middle-ground. What they’re looking for in exchange for dropping prices is for the administration to push back the tariffs. That’s part of the Pfizer deal.
I do think it will make a difference and pharma companies will concede, even if not fully to what Trump wants. Even if it’s a little bit, that’s still better than nothing.
...Today's Sponsors
Today's Sponsor